The European Human Exposome Network (EHEN) third newsletter announces the launch of its Toolbox and introduces the health impact of exposome reaserach and the diseases studied by the nine EHEN projects, including EXIMIOUS.

Our partner in the spotlight series continues, and we’re glad to present the Norwegian Institute of Public Health (NIPH). In EXIMIOUS, the team at NIPH makes use of CyTOF to identify immune-cell signatures.

More than 70 participants joined the second EXIMIOUS Symposium. Did you miss it? Read about it here and watch the full recording.

The European Human Exposome Network (EHEN) just released its second newsletter, with updates from the network’s working groups and its exposome projects, including EXIMIOUS.

“The EXIMIOUS project—Mapping exposure-induced immune effects: connecting the exposome and the immunome” has been published online in Environmental Epidemiology.

Join us online on 3 february 2022 at 16:00 – 18:00 (CET) for the EXIMIOUS Symposium “Immune-mediated diseases: an interplay between environment and genetics”.

We’re glad to welcome the New Year by continuing our partner in the spotlight series. Under the spotlight today is the Vall d’Hebrón Research Institute (VHIR).

This month we’re pleased to introduce accelopment Schweiz AG, our partner in the lead for the project’s communication, dissemination and exploitation.